Related Experiment Video
Updated: May 21, 2026

An Intact Pericardium Ischemic Rodent Model
Published on: September 2, 2021
Clinical presentation and long-term follow-up of perimyocarditis
Alessandra Buiatti1, Marco Merlo, Bruno Pinamonti
1Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy. elam4@libero.it
Background:
The natural history of perimyocarditis (PMY) is not yet completely known. We aimed to analyse the clinical laboratory data of PMY at diagnosis and during follow-up, in order to assess the natural history and prognostic stratification of the disease (including different aetiology).
Methods:
We enrolled 62 consecutive patients (men 79%, aged 38 ± 18 years) with PMY (84% idiopathic, 8% autoimmune, 8% infective) from August 2002 to July 2010. The diagnosis has been made according to clinical and laboratory data (significant increase of troponin I in all patients). After at least 1 year (mean follow-up: 1635 ± 298 days), 59 patients (95%) had available data.
Results:
Chest pain was present in 59 patients (95%), flu-like syndrome in 36 (58%) and pericardial rubs in 15 (24%). None of the patients showed heart failure at presentation. At admission, eight patients (13%) presented mild-moderate left ventricular systolic dysfunction, 13 (22%) showed wall motion abnormalities, and 10 (17%) showed mild pericardial effusion. At 1 year no patients died, developed heart failure or showed abnormal echocardiogram. NSAIDs were the first choice therapy in 61 (98%) patients with clinical resolution in 58 (95%) of them. Seven patients (12%) experienced intermittent recurrences without development of constrictive pericarditis or heart failure.
Conclusion:
This study underlines the benign mid- to long-term outcome of PMY regardless of clinical laboratory characteristics at presentation, different aetiology and possibility of relapses; minimizing the role of endomyocardial biopsy in these specific patients.
Insights
Perimyocarditis (PMY) generally has a favorable long-term prognosis, with most patients experiencing symptom resolution and no significant cardiac complications. Recurrences are possible but typically do not lead to severe heart issues.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- The natural history and prognostic factors of perimyocarditis (PMY) require further elucidation.
- Understanding PMY's clinical course is crucial for effective patient management and stratification.
Purpose of the Study:
- To analyze clinical and laboratory data of PMY patients at diagnosis and during follow-up.
- To assess the natural history and prognostic stratification of PMY, considering various etiologies.
Main Methods:
- 62 consecutive PMY patients (84% idiopathic) were enrolled between 2002 and 2010.
- Diagnosis was based on clinical and laboratory data, including elevated troponin I.
- Follow-up data was available for 59 patients (95%) after a mean of 1635 days.
Main Results:
- Chest pain (95%) and flu-like syndrome (58%) were common presenting symptoms.
- No patients presented with heart failure; mild left ventricular dysfunction or wall motion abnormalities were observed in some.
- At 1-year follow-up, no deaths, heart failure, or echocardiographic abnormalities occurred. NSAIDs achieved 95% clinical resolution.
- Seven patients (12%) had recurrences without developing constrictive pericarditis or heart failure.
Conclusions:
- PMY demonstrates a benign mid- to long-term outcome irrespective of initial presentation, etiology, or relapses.
- The findings suggest a limited role for endomyocardial biopsy in managing PMY.
- Therapeutic strategies focusing on NSAIDs yield high rates of clinical resolution.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction
Endocarditis III: Medical Management
